| 2281- | VitK2, | The biological responses of vitamin K2: A comprehensive review |
| - | Review, | Var, | NA |
| 2280- | VitK2, | Vitamin K2 induces non-apoptotic cell death along with autophagosome formation in breast cancer cell lines |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | AML, | HL-60 |
| 2279- | VitK2, | Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways |
| - | in-vitro, | Bladder, | T24/HTB-9 | - | in-vitro, | Bladder, | J82 | - | in-vitro, | Nor, | HEK293 | - | in-vitro, | Nor, | L02 | - | in-vivo, | NA, | NA |
| 2278- | VitK2, | VitK3, | VitC, | Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect |
| - | Review, | Var, | NA |
| 2277- | VitK2, | Vitamin K2 suppresses rotenone-induced microglial activation in vitro |
| - | in-vitro, | Nor, | BV2 | - | NA, | AD, | NA | - | NA, | Park, | NA |
| 2276- | VitK2, | Vitamin K2 (MK-7) Intercepts Keap-1/Nrf-2/HO-1 Pathway and Hinders Inflammatory/Apoptotic Signaling and Liver Aging in Naturally Aging Rat |
| - | in-vivo, | Nor, | NA |
| 2275- | VitK2, | Delivery of the reduced form of vitamin K2(20) to NIH/3T3 cells partially protects against rotenone induced cell death |
| - | in-vitro, | Nor, | NIH-3T3 |
| 2274- | VitK2, | Vitamin K2 Modulates Mitochondrial Dysfunction Induced by 6-Hydroxydopamine in SH-SY5Y Cells via Mitochondrial Quality-Control Loop |
| - | in-vitro, | Nor, | SH-SY5Y |
| 2285- | VitK2, | New insights into vitamin K biology with relevance to cancer |
| - | Review, | Var, | NA |
| 4188- | VitK2, | Vitamin K2 protects against aluminium chloride-mediated neurodegeneration |
| - | in-vivo, | NA, | NA |
| 4091- | VitK2, | The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease |
| - | Review, | AD, | NA |
| 4090- | VitK2, | ProBio, | Vitamin K2 Holds Promise for Alzheimer's Prevention and Treatment |
| - | Review, | AD, | NA |
| 1840- | VitK2, | The mechanisms of vitamin K2-induced apoptosis of myeloma cells |
| - | in-vitro, | Melanoma, | NA |
| 1833- | VitK2, | Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells |
| - | in-vitro, | BC, | HS587T | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | SUM159 |
| 1830- | VitK2, | Vitamin K Intake and Risk of Lung Cancer: The Japan Collaborative Cohort Study |
| - | Study, | Lung, | NA |
| 1829- | VitK2, | Vitamin K: New insights related to senescence and cancer metastasis |
| - | Review, | Var, | NA |
| 1825- | VitK2, | Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial |
| - | Analysis, | Pca, | NA |
| 1824- | VitK2, | Vitamin K and its analogs: Potential avenues for prostate cancer management |
| - | Review, | Pca, | NA |
| 1823- | VitK2, | VitK3, | Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells |
| - | in-vitro, | CRC, | NA | - | in-vivo, | NA, | NA |
| 1822- | VitK2, | Vitamin K: A novel cancer chemosensitizer |
| - | Review, | Var, | NA |
| 1817- | VitK2, | Research progress on the anticancer effects of vitamin K2 |
| - | Review, | Var, | NA |
| 1818- | VitK2, | New insights on vitamin K biology with relevance to cancer |
| - | Review, | Var, | NA |
| 1816- | VitK2, | Role of Vitamin K in Selected Malignant Neoplasms in Women |
| - | Review, | Var, | NA |
| 1213- | VitK2, | Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4 |
| - | in-vitro, | HCC, | HepG2 |
| 1214- | VitK2, | Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells |
| - | in-vitro, | Bladder, | T24/HTB-9 | - | in-vitro, | Bladder, | J82 |
| 1211- | VitK2, | Mechanisms of PKC-Mediated Enhancement of HIF-1α Activity and its Inhibition by Vitamin K2 in Hepatocellular Carcinoma Cells |
| - | in-vitro, | HCC, | HUH7 |
| 1212- | VitK2, | Vitamin K2 stimulates osteoblastogenesis and suppresses osteoclastogenesis by suppressing NF-κB activation |
| - | in-vitro, | ostP, | NA |
| 1828- | VitK3, | VitC, | Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C |
| - | in-vivo, | GBM, | NA |
| 1837- | VitK3, | VitC, | Alpha-Tocopheryl Succinate Inhibits Autophagic Survival of Prostate Cancer Cells Induced by Vitamin K3 and Ascorbate to Trigger Cell Death |
| - | in-vivo, | Pca, | NA |
| 1835- | VitK3, | VitC, | Potential therapeutic application of the association of vitamins C and K3 in cancer treatment |
| - | Review, | Var, | NA |
| 1834- | VitK3, | PDT, | Effects of Vitamin K3 Combined with UVB on the Proliferation and Apoptosis of Cutaneous Squamous Cell Carcinoma A431 Cells |
| - | in-vitro, | Melanoma, | A431 |
| 1838- | VitK3, | PDT, | Photodynamic Effects of Vitamin K3 on Cervical Carcinoma Cells Activating Mitochondrial Apoptosis Pathways |
| - | in-vitro, | Cerv, | NA |
| 1832- | VitK3, | VitC, | Vitamin K3 and vitamin C alone or in combination induced apoptosis in leukemia cells by a similar oxidative stress signalling mechanism |
| - | in-vitro, | AML, | K562 |
| 1831- | VitK3, | VitK2, | The anticancer effects of vitamin K |
| - | Review, | Var, | NA |
| 1839- | VitK3, | Vitamin K3 derivative inhibits androgen receptor signaling in targeting aggressive prostate cancer cells |
| - | in-vitro, | Pca, | NA |
| 1827- | VitK3, | A biophysical approach to menadione membrane interactions: relevance for menadione-induced mitochondria dysfunction and related deleterious/therapeutic effects |
| - | Analysis, | Var, | NA |
| 1826- | VitK3, | PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 |
| 1820- | VitK3, | Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells |
| - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | SW-620 |
| 1815- | VitK3, | VitK2, | Vitamin K |
| - | Review, | Nor, | NA |
| - | in-vitro, | Oral, | NA | - | in-vitro, | Nor, | HEK293 | - | in-vitro, | Nor, | HaCaT |
| 2428- | VitK3, | Vitamin K3 and K5 are inhibitors of tumor pyruvate kinase M2 |
| - | Study, | Var, | NA |
| 2372- | VitK3, | The role of pyruvate kinase M2 in anticancer therapeutic treatments |
| - | Review, | Var, | NA |
| 8508- | VO, | Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study |
| - | Trial, | Nor, | NA |
| 7921- | VT, | Vitexin's Role in Colon Cancer Apoptosis: AMPK/mTOR Pathway Modulation Explored Through Experimental and Computational Approaches |
| - | in-vitro, | Colon, | Caco-2 |
| 7920- | VT, | Vitexin Induces Apoptosis in MCF-7 Breast Cancer Cells through the Regulation of Specific miRNAs Expression |
| - | in-vitro, | BC, | MCF7 |
| 7919- | VT, | Apoptosis triggered by vitexin in U937 human leukemia cells via a mitochondrial signaling pathway |
| - | in-vitro, | AML, | U937 |
| 7916- | VT, | Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway |
| - | in-vitro, | HCC, | NA |
| 7915- | VT, | A Brief Review on the Neuroprotective Mechanisms of Vitexin |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 7914- | VT, | Vitexin induces apoptosis through mitochondrial pathway and PI3K/Akt/mTOR signaling in human non-small cell lung cancer A549 cells |
| - | vitro+vivo, | Lung, | A549 |
| 7913- | VT, | Review of the effects of vitexin in oxidative stress-related diseases |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid